Kineta Inventory Turnover Ratio 2014-2024 | KANT
Kineta inventory turnover ratio from 2014 to 2024. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
| Kineta Inventory Turnover Ratio Historical Data |
| Date |
|
|
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.005B |
|
Kineta, Inc. is a clinical-stage biotechnology company. It develops next-generation immunotherapies that address the major challenges with current cancer therapy. The company's lead asset is KVA12123, a novel VISTA blocking immunotherapy. Kineta merged with Yumanity Therapeutics, Inc., and is based in Seattle.
|
